CCL2 and neoplasm: In colitis-associated cancer, gut microbiota-derived LPS reprogrammed macrophage cytokine output through a 2-step process: first stimulating colonic epithelial cells to release CCL2, which recruited monocyte-like macrophages (MLMs) to the tumor site, and subsequently activating these MLMs to secrete high levels of IL-1β.